全病程管理
Published by:
浙江海心智惠科技有限公司
Description
全病程管理是提供给湖南省乳腺癌专病联盟的医生使用的移动客户端产品，医生可以通过该产品方便快捷进行上下级转诊，患者全病程管理，研究癌症治疗数据，提升癌症治疗规范
Screenshots
全病程管理 FAQ
-
Is 全病程管理 free?
Yes, 全病程管理 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 全病程管理 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 全病程管理 cost?
全病程管理 is free.
-
What is 全病程管理 revenue?
To get estimated revenue of 全病程管理 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Hong Kong SAR China yet.
Ratings History
全病程管理 Reviews
No Reviews in Hong Kong SAR China
App doesn't have any reviews in Hong Kong SAR China yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
全病程管理 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
觅健医生版
N/A
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
创想医生
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
乐问医学
乐问医学-做大数据+AI与生命科学的链接者
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
易随诊医生
|
Unlock
|
Unlock
|
1
|
|
2 years ago | |
土拨鼠博士
|
Unlock
|
Unlock
|
0
|
|
11 months ago | |
术愈-肺部肿瘤康复管理
赋能肺癌患者术后加速康复
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
圆心医互
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
健康浏阳医生端
|
Unlock
|
Unlock
|
0
|
|
10 months ago | |
WeDoc
|
Unlock
|
Unlock
|
0
|
|
4 weeks ago | |
乳腺中心
乳腺疾病管理工具
|
Unlock
|
Unlock
|
0
|
|
6 months ago |
全病程管理 Installs
Last 30 days
全病程管理 Revenue
Last 30 days全病程管理 Revenue and Downloads
Gain valuable insights into 全病程管理 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- 浙江海心智惠科技有限公司
- Languages
- English
- Recent release
- 1.4.9 (1 year ago )
- Released on
- Sep 15, 2021 (3 years ago )
- Also available in
- China , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.